10210
Ana Teresa Timóteo
49. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death
from cardiovascular causes. N Engl J Med. 2007; 356: 2257-2271.
50. Dormondy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macrovascular
events in patients with type 2 diabetes in the PROactive study: a randomised controlled trial.
Lancet. 2005; 366: 1279-1289.
51. Monami M, Ahrin B, Dicembrini I, et al. DPP-4 inhibitors and cardiovascular risk: a meta-anal-
ysis of randomised clinical trials. Diabetes Obes Metab. 2013; 15: 112-120.
52. Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients
with type 2 diabetes mellitus. N Engl J Med. 2013; 369: 1317-1326.
53. White WB, Cannon CP, Heller SR, et al. Alogliptin after acute coronary syndrome in patients
with type 2 diabetes. N Engl J Med. 2013; 369: 1327-1335.
54. Brunton SA. The potential role of sodium glucose co-transporter 2 inhibitor in the early
treatment of type 2 diabetes mellitus. Int J Clin Pract. 2015; 69: 1071-1087.
55. Stringhini S, Sabia S, Shipley M, et al. Association of socio-economic position with health
behaviours and mortality. JAMA. 2010; 303: 1159-1166.
56. Albert MA, Glynn RJ, Buring J, et al. Impact of traditional and novel risk factors in the
relationship between socio-economic status and incident cardiovascular events. Circulation.
2006; 114: 2619-2626.
57. Mookadarm F, Arthur HM. Social support and its relationship to morbidity and mortality after
acute myocardial infarction: Systematic overview. Arch Intern Med. 2004; 164: 1514-1518.
58. Eller NH, Netterstrom B, Gyntelberg F. Work-related psychosocial factors and the develop-
ment of ischemic heart disease: A systematic review. Cardiol Rev. 2009; 17: 83-97.
59. Eaker ED, Sullivan LM, Kelly-Hayes M, et al. Mental status, mental strain, and risk of coronary
heart disease on total mortality: the Framingham Offspring Study. Psychosom Med. 2007; 69:
509-513.
60. Nicholson A, Kuper H, Hemingway H. Depression as an etiological and prognostic factor
in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54
observational studies. Eur Heart J. 2006; 27: 2763-2774.
61. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in
patients with coronary heart disease: a meta-analysis: Psychosom Med. 2004; 66: 802-813.
62. Roest AM, Martens EJ, Denollet J, et al. Prognostic association of anxiety post myocardial
infarction with mortality and new coronary events: a meta-analysis. Psychosom Med. 2010;
72: 563-569.
63. Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease:
a meta-analysis review of prospective evidence. J Am Coll Cardiol. 2009; 53: 936-946.
64. Denollet J, Schiffer AA, Spek V. A general propensity of psychosocial distress affects car-
diovascular outcomes: evidence from research on the type D (distressd) personality profile.
Circ Cardiovasc Qual Outcomes. 2010; 3: 546-557.
65. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk
of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the
INTERHEART study): case-control study. Lancet. 2004; 364: 953-962.
